The hexosamine biosynthesis pathway in human bronchial epithelial cell transformation
Ended Project Grant Awarded Last action
- Award ID
- R03CA223637
- Recipient
-
Lovelace Biomedical And Environmental Research Institute, Inc. UEI N1UBCLRAPNG6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $214,796
Award facts
- Assistance listing
- 93.393 Cancer Cause and Prevention Research
- Completion date
- Originally
- Funding
-
- $215,863.98 Federal
- -$1,068.01 Non-federal
- Place of performance
- Albuquerque, NM 87108, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$1,068 | $0 | |
| Amendment | -$1,068 | -$1,068 | |
| Amendment | $109,000 | $0 | |
| Original award | $109,000 | $0 |
Quick answers
Who received award R03CA223637?
R03CA223637 was awarded to Lovelace Biomedical And Environmental Research Institute, Inc. by National Cancer Institute (National Institutes of Health) on July 6, 2018.
How much is award R03CA223637 worth?
$214,796 has been obligated on R03CA223637: $215,864 in federal funding and -$1,068 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award